DARE Chart
- 52-Week Range: $0.94 - $2.13
- Market Capitalization: $89.79M
- Short Percentage: 0%
- Target Price: $7.20
- Shares Outstanding: 84.71M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
DARE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Daré Bioscience to Participate in H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 16th
- Trading Penny Stocks? Top Stock Market News for March 31st, 2022PennyStocks | March 31st
- Daré Bioscience Reports Full-Year 2021 Financial Results and Provides a Company UpdateGlobeNewsWire | March 31st
- Daré Bioscience to Present at the Maxim 2022 Virtual Growth ConferenceGlobeNewsWire | March 22nd
- Daré Bioscience's One-Time Bacterial Vaginosis Treatment Scores FDA ApprovalBenzinga | December 7th
- Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 10th
- Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company UpdateGlobeNewsWire | November 10th
Company Info
Website: https://www.darebioscience.com
Address: 3655 Nobel Drive, San Diego, CA, United States, 92122
Sector: Healthcare
Industry: Biotechnology
Full time employees: 20
Address: 3655 Nobel Drive, San Diego, CA, United States, 92122
Sector: Healthcare
Industry: Biotechnology
Full time employees: 20
$DARE not good
$DARE Who’s still buying calls?
$DARE when's the offering?
$DARE up we go
$DARE buying time
added
$DARE added more calls on that drop
$DARE I'll say it again slowwwllyyyy! Better stocks to short by far
$DARE Holding
$DARE lmao wtf was that
$DARE has just been halted from trading.